Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
8,454 Dovepress* 5,224 1,286+ 1,920 6,510
PubMed Central* 0 1,944 900 1,944
Totals 5,224 3,230 2,820 8,454
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar